Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Membungkam buku: Mengapa negara takut pada pengetahuan dan pikiran kritis

Tumpukan buku-buku non-fiksi yang mengeksplorasi topik politik di Sidoarjo, Jawa Timur.Subekti Mochamad Eko/Shutterstock● Pascademo besar Agustus lalu, polisi menangkap sejumlah demonstran dan m...

STEM VS Soshum: Perlukah kita memperdebatkan dikotomi ini?

CC BYPerdebatan antara rumpun ilmu sains dan teknologi (saintek) dengan ilmu sosial dan humaniora (soshum) kembali mencuat di ruang publik digital. Isu ini berawal dari kebijakan beasiswa pemerintah y...

Fatwa haram ‘sound horeg’: Benarkah Islam menolak perkembangan teknologi?

● Islam kerap dituduh sebagai antiteknologi karena kerap melarang perkembangan teknologi, termasuk sound horeg.● Penolakan Islam terhadap teknologi bukan karena keyakinan agama, tetapi leb...